Peter Ferenci

3.6k total citations
84 papers, 2.6k citations indexed

About

Peter Ferenci is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Peter Ferenci has authored 84 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hepatology, 35 papers in Epidemiology and 17 papers in Rheumatology. Recurrent topics in Peter Ferenci's work include Hepatitis C virus research (49 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (17 papers). Peter Ferenci is often cited by papers focused on Hepatitis C virus research (49 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (17 papers). Peter Ferenci collaborates with scholars based in Austria, Germany and United States. Peter Ferenci's co-authors include Alfred Gangl, Wolfgang Jessner, G Grimm, Friedrich Wrba, Harald Hofer, Christian Datz, Franz Hackl, Petra Steindl, Ola Weiland and Marı́a Buti and has published in prestigious journals such as The Lancet, Gastroenterology and American Journal of Clinical Nutrition.

In The Last Decade

Peter Ferenci

83 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Ferenci Austria 27 1.8k 1.6k 268 241 195 84 2.6k
Eray Yagmur Germany 24 705 0.4× 1.1k 0.7× 108 0.4× 54 0.2× 318 1.6× 61 2.2k
Kazumichi Abe Japan 22 743 0.4× 754 0.5× 207 0.8× 80 0.3× 239 1.2× 122 1.4k
S. Chris Pappas United States 24 1.8k 1.0× 1.4k 0.9× 73 0.3× 34 0.1× 698 3.6× 66 2.2k
Juan A. del Olmo Spain 21 2.1k 1.2× 1.7k 1.1× 65 0.2× 36 0.1× 846 4.3× 49 2.9k
E. Ventura Italy 17 385 0.2× 334 0.2× 66 0.2× 100 0.4× 184 0.9× 77 1.1k
Keizo Anzai Japan 28 624 0.3× 1.4k 0.9× 48 0.2× 90 0.4× 474 2.4× 117 2.6k
Manabu Hayashi Japan 23 250 0.1× 380 0.2× 69 0.3× 71 0.3× 205 1.1× 109 1.6k
Itzhak Rosner Israel 23 213 0.1× 373 0.2× 807 3.0× 47 0.2× 259 1.3× 74 1.9k
Neşe İmeryüz Türkiye 27 302 0.2× 988 0.6× 150 0.6× 141 0.6× 363 1.9× 78 1.9k
Emer Fitzpatrick United Kingdom 25 651 0.4× 742 0.5× 63 0.2× 69 0.3× 674 3.5× 68 1.8k

Countries citing papers authored by Peter Ferenci

Since Specialization
Citations

This map shows the geographic impact of Peter Ferenci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ferenci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ferenci more than expected).

Fields of papers citing papers by Peter Ferenci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ferenci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ferenci. The network helps show where Peter Ferenci may publish in the future.

Co-authorship network of co-authors of Peter Ferenci

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ferenci. A scholar is included among the top collaborators of Peter Ferenci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ferenci. Peter Ferenci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chalasani, Naga, Cosme Manzarbeitia, Peter Ferenci, et al.. (2005). Peginterferon alfa‐2a for hepatitis C after liver transplantation. Hepatology. 41(2). 289–298. 195 indexed citations
2.
Datz, Christian, Felix Stickel, Claus Hellerbrand, et al.. (2005). TGF-β1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis. Cytokine. 31(2). 142–148. 33 indexed citations
3.
Zeuzem, Stefan, Marı́a Buti, Peter Ferenci, et al.. (2005). Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. Journal of Hepatology. 44(1). 97–103. 334 indexed citations
4.
Temmel, Andreas F P, et al.. (2005). Dysfunction of the liver affects the sense of smell. Wiener klinische Wochenschrift. 117(1-2). 26–30. 11 indexed citations
5.
Formann, Elisabeth, Rudolf Stauber, Doris‐Maria Denk, et al.. (2004). Sudden Hearing Loss in Patients with Chronic Hepatitis C Treated with Pegylated Interferon/Ribavirin. The American Journal of Gastroenterology. 99(5). 873–877. 32 indexed citations
6.
Ferenci, Peter, Hermann Laferl, H. Brünner, et al.. (2003). Prospective evaluation of the 24 hour interferon-induced decline in hepatitis C virus genotype 1 load to predict response to peginterferon-alfa2a/ribavirin combination therapy. Gastroenterology. 124(4). A767–A767. 6 indexed citations
7.
Ferenci, Peter. (2003). How to identify the genetic basis of gastrointestinal and liver diseases?: Table 1. Gut. 52(suppl 2). ii6–ii9. 3 indexed citations
8.
Ferenci, Peter. (2003). Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies. Journal of Antimicrobial Chemotherapy. 53(1). 15–18. 65 indexed citations
9.
Peck‐Radosavljevic, Markus, Martina Wichlas, Anna Kreil, et al.. (2002). Rapid suppression of hematopoiesis by standard or pegylated interferon-α. Gastroenterology. 123(1). 141–151. 109 indexed citations
10.
Jessner, Wolfgang, et al.. (2001). Effect of pegylated (PEG 40kd) interferon (IFN)α-2a on early virus elimination in patients infected with HCV subtype 1. Gastroenterology. 120(5). A29–A29. 2 indexed citations
11.
12.
Ferenci, Peter. (2000). [Therapy of chronic hepatitis C].. PubMed. 150(23-24). 481–5. 1 indexed citations
13.
Müller, Christian, Johann Pidlich, Edward Penner, et al.. (1998). Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron. European Journal of Gastroenterology & Hepatology. 10(10). 865–870. 84 indexed citations
14.
Novacek, Gottfried, et al.. (1992). Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria. PubMed. 4. 76–80. 3 indexed citations
15.
Grimm, G, et al.. (1990). Evoked potentials in assessment and follow-up of patients with Wilson's disease. The Lancet. 336(8721). 963–964. 43 indexed citations
16.
Ferenci, Peter, W. Vogel, H Pristautz, et al.. (1990). One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2b. Journal of Hepatology. 11. S50–S53. 23 indexed citations
17.
Ferenci, Peter, et al.. (1989). Intestinal neuronal degeneration in a patient with chronic idiopathic intestinal pseudoobstruction. Digestive Diseases and Sciences. 34(1). 123–128. 5 indexed citations
18.
Vogelsang, Harald, et al.. (1988). Acidic colonic microclimate--possible reason for false negative hydrogen breath tests.. Gut. 29(1). 21–26. 41 indexed citations
19.
Ferenci, Peter, Thomas Stehlé, Josef Ebner, Rainer Schmid, & Dieter Häussinger. (1988). Uptake and catabolism of γ-aminobutyric acid by the isolated perfused rat liver. Gastroenterology. 95(2). 402–407. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eray Yagmur Breakdown of academic impact, for papers by Kazumichi Abe Breakdown of academic impact, for papers by S. Chris Pappas Breakdown of academic impact, for papers by Juan A. del Olmo Breakdown of academic impact, for papers by E. Ventura Breakdown of academic impact, for papers by Keizo Anzai Breakdown of academic impact, for papers by Manabu Hayashi Breakdown of academic impact, for papers by Itzhak Rosner Breakdown of academic impact, for papers by Neşe İmeryüz Breakdown of academic impact, for papers by Emer Fitzpatrick
Rankless by CCL
2026